Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study-Reference-Cited by-同舟云学术

Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study

Published:2005-05-16 Issue:9 Volume:20 Page:1514-1524
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Siris Ethel S,Harris Steven T,Eastell Richard,Zanchetta Jose R,Goemaere Stefan,Diez-Perez Adolfo,Stock John L,Song Jingli,Qu Yongming,Kulkarni Pandurang M,Siddhanti Suresh R,Wong Mayme,Cummings Steven R

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference32 articles.

1. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial;Ettinger;JAMA,1999

2. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial;Delmas;J Clin Endocrinol Metab,2002

3. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: Results from the MORE trial;Delmas;Bone,2003

4. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE Trial;Cauley;Breast Cancer Res Treat,2001

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of bone turnover markers in diagnosis, monitoring, and pathological fractures of osteoporosis;Turkish Journal of Trauma and Emergency Surgery;2024

2. Sequential management of postmenopausal health and osteoporosis: An update;Maturitas;2023-11

3. Introducing a novel therapeutic supplement for osteoporosis: Remedial, cytotoxicity and antioxidant effects of plant extract green-formulated gold nanoparticles;Journal of Engineering Research;2023-07

4. Recommendations for the Pharmacological Treatment of Osteoporosis – Update 2023 of the German Osteoporosis Guideline;Osteologie;2023-05

5. Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021;Frontiers in Endocrinology;2023-04-18